Business
Result of Annual General Meeting
Result of Annual General Meeting.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n\n \nOXB\nResult of Annual General Meeting and Confirmation of Board Changes\n \nOxford, UK - 11 June 2025: OXB (LSE: OXB) (the \"Company\"), a global quality and innovation-led cell and gene therapy CDMO, today announces that all proposed resolutions were duly passed at its Annual General Meeting (\"AGM\"), held at 3 pm on 11 June 2025 in Oxford. As proposed in the Notice of AGM, all resolutions were decided by poll vote.\n \nThe full text of all the resolutions can be viewed in the Notice of AGM by visiting the Company's website at www.oxb.com\n \nCopies of the document setting out the above resolutions passed at the 2025 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism\n \nOn the Record Date (9 June 2025) there were 106,127,365 ordinary shares of 50 pence each in issue, each carrying one vote per share.\n \nFurther to the announcement by the Company on 9 April 2025, Stuart Henderson has stepped down from the Company's Board of Directors (the \"Board\") with immediate effect following the conclusion of today's AGM.\n \nFollowing Stuart Henderson's departure, Colin Bond, who joined the Board as an Independent Non-Executive Director in January 2025, will succeed Mr. Henderson as Audit Committee Chair and Peter Soelkner, who joined the Board as an Independent Non-Executive Director in March 2024, will assume the position of Vice Chair. These changes are effective immediately.\n \n\n\n\n\n \n\n\n \n \n \n \nResolutions\n\n\nVotes For (incl. votes at the Chair's discretion)\n\n\n \n \n \n% of votes cast\n\n\nVotes Against\n\n\n \n \n \n% of votes cast\n\n\nVotes Withheld*\n\n\nTotal votes cast**\n\n\nResult\n\n\n\n\n \n\n\nOrdinary resolutions\n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n \n\n\n\n\n1\n\n\nTo receive and adopt the Company's Annual Report and accounts for the financial year ended 31 December 2024, the Directors' Report, and the Report of the Independent Auditors on those accounts and reports.\n\n\n 78,099,206\n\n\n99.99%\n\n\n 4,993\n\n\n0.01%\n\n\n \n \n \n \n247,911\n\n\n \n \n \n \n78,104...